发布求助
文献互助 智能选刊 最新文献

Pharmacy practice management quarterly最新文献

筛选
英文 中文
Influencing physician prescribing. 影响医生的处方。
Pharmacy practice management quarterly Pub Date : 1999-10-01
R Segal, F Wang
{"title":"Influencing physician prescribing.","authors":"R Segal,&nbsp;F Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The drug use process suffers from problems related to quality and cost that have not responded well to administrative or educational interventions. In many cases, attempts to improve the quality of physician prescribing have been clumsy, often based on intuition. This article begins by describing the drug use process and the role of prescribing in that process. In the following section, we describe what is known about how physicians make drug choice decisions. The paper concludes with suggestions, based on evidence, about the design of strategies for influencing prescribing.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 3","pages":"30-50"},"PeriodicalIF":0.0,"publicationDate":"1999-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21598056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation in pregnancy. 妊娠抗凝。
Pharmacy practice management quarterly Pub Date : 1999-10-01
S M Bates, J S Ginsberg
{"title":"Anticoagulation in pregnancy.","authors":"S M Bates,&nbsp;J S Ginsberg","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The use of anticoagulants during pregnancy for prevention and treatment of venous thromboembolism and prevention of systemic embolism in patients with valvular heart disease presents several problems. This article discusses the complications associated with warfarin, unfractionated heparin, and low-molecular-weight heparin as well as the benefits of each. While a literature review turned up only limited data, the authors extrapolated from existing data recommendations for treatment during pregnancy, finding that oral warfarin should be replaced by heparin during pregnancy, especially from the 6th to the 12th week and near term. In addition, treatment recommendations are provided for different stages of pregnancy, delivery, and postpartum.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 3","pages":"51-60"},"PeriodicalIF":0.0,"publicationDate":"1999-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21598057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining the differences among cost savings, cost avoidance, and cost reduction. 确定成本节约、成本避免和成本降低之间的差异。
Pharmacy practice management quarterly Pub Date : 1999-10-01
K B Howard, D S Pathak
{"title":"Determining the differences among cost savings, cost avoidance, and cost reduction.","authors":"K B Howard,&nbsp;D S Pathak","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cost savings, cost avoidance, and cost reduction are important factors to measure when valuing clinical pharmacy services. Currently, there are no universally accepted definitions for these terms. The authors of this study evaluated 44 articles which claimed to measure cost savings, cost avoidance, or cost reduction associated with clinical pharmacy services, and offered recommendations for when it would be appropriate to use these terms. Based on the results of our analysis, it is evident that controversy exists in the literature when determining if services result in cost avoidance or cost reduction. Therefore, there is a need for universally accepted definitions of these terms so that future research may evaluate such factors uniformly.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 3","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"1999-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21598055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical care and health outcomes in community settings: a matched pair analysis of perceptions of hypertensive patients versus pharmacists. 社区环境中的药学服务和健康结果:高血压患者与药师观念的配对分析
Pharmacy practice management quarterly Pub Date : 1999-07-01
D Franic, D S Pathak, D Mott
{"title":"Pharmaceutical care and health outcomes in community settings: a matched pair analysis of perceptions of hypertensive patients versus pharmacists.","authors":"D Franic,&nbsp;D S Pathak,&nbsp;D Mott","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Unlabelled: </strong>This study aimed to: (1) assess the level of pharmaceutical care delivered by pharmacists, and (2) compare patients' and pharmacists' health related quality of life (HRQOL) assessments for patients receiving antihypertensive therapy as an indicator of the delivery of pharmaceutical care.</p><p><strong>Design: </strong>An exploratory, cross-sectional study using matched pair survey instruments.</p><p><strong>Setting: </strong>Columbus, Ohio.</p><p><strong>Participants: </strong>Patients in a community setting prescribed antihypertensive medication and their pharmacists were selected for study participation.</p><p><strong>Interventions: </strong>Parallel surveys distributed to patients and their pharmacists.</p><p><strong>Main outcome measures: </strong>Level of pharmaceutical care delivered by pharmacists, and perceived patient viewpoints on: clinical outcomes (blood pressure control, and side effects due to antihypertensive medication) and humanistic outcomes (overall, emotional and physical HRQOL) by patients and pharmacists.</p><p><strong>Results: </strong>Analysis of 52 useable matching surveys of pharmacists and patients indicated that nearly all pharmacists counsel patients and two thirds of pharmacists counsel and monitor drug therapy. This is consistent with providing the minimal OBRA 90 requirements. When comparing patient and pharmacist perceived patient clinical as well as humanistic outcomes, a high level of association was reported between the two groups.</p><p><strong>Conclusions: </strong>The results of this study suggest that pharmacists are cognizant of patient clinical and humanistic outcomes and hence, they are in an excellent position to improve patient outcomes by making appropriate drug therapy changes.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 2","pages":"1-17"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21417386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-offset analysis of aprotinin in high-risk coronary artery bypass. 高危冠状动脉搭桥术中抑肽酶的成本抵消分析。
Pharmacy practice management quarterly Pub Date : 1999-07-01
P D Meek, P H Vlasses, M E Sura, R E Walsh, L C Vermeulen
{"title":"Cost-offset analysis of aprotinin in high-risk coronary artery bypass.","authors":"P D Meek,&nbsp;P H Vlasses,&nbsp;M E Sura,&nbsp;R E Walsh,&nbsp;L C Vermeulen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Aprotinin, a naturally occurring protease inhibitor derived from bovine lung, is used prophylactically to minimize the amount of perioperative blood loss in patients undergoing coronary artery bypass graft surgery who are at high risk for excessive bleeding. A retrospective multicenter evaluation of aprotinin use was performed in high-risk coronary artery bypass graft patients treated either with aprotinin or according to usual-care to assess (1) differences in demographic and medical history characteristics, and (2) clinical and economic outcomes associated with their care. This study suggests that in many cases, the cost of aprotinin is offset by reductions in overall cost. Additional study is required to better understand this potential. In other cases, however, a more conservative approach to aprotinin use appears to be warranted.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 2","pages":"18-25"},"PeriodicalIF":0.0,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21417387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy. 口服昂丹司琼与丙氯哌嗪预防中度致吐性化疗后恶心呕吐的成本-效果分析。
Pharmacy practice management quarterly Pub Date : 1999-04-01
W J Kwong, T V Parasuraman
{"title":"Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.","authors":"W J Kwong,&nbsp;T V Parasuraman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The article reports a study comparing the cost-effectiveness of ondansetron tablets and prochlorperazine capsules in preventing nausea and vomiting after moderately emetogenic chemotherapy in an outpatient setting. A decision analysis model was constructed to compare the cost-effectiveness of the two antiemetics from the perspective of third party health care payers. Probability estimates of the model were derived from a reanalysis of data obtained from a clinical trial directly comparing the two antiemetics. Effectiveness was defined as the number of patients with no emetic episodes and no drug-related adverse events during the 3-day period after receiving chemotherapy. Cost-estimates were based on Average Wholesale Price for medications and national average for hospital services adjusted to 1996 U.S. dollars. Cost-effectiveness ratios for ondansetron and prochlorperazine were $261 and $268 per effectively treated patient, respectively. A series of sensitivity analyses were performed to identify the limits of generalizability of study results. Despite the initial price differential between the two antiemetics, ondansetron was more cost effective than prochlorperazine when the duration of therapy was shorter than 3 days, the total cost of rescue therapy per patient was more than $71, the treatment cost of adverse events was less than $24, the complete relief rate for ondansetron was greater than 58.9 percent, and the complete relief rate for prochlorperazine was less than 26.5 percent.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 1","pages":"28-41"},"PeriodicalIF":0.0,"publicationDate":"1999-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21220011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient record documentation and confidentiality. 患者记录文件和保密性。
Pharmacy practice management quarterly Pub Date : 1999-04-01
{"title":"Patient record documentation and confidentiality.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 1","pages":"57-62"},"PeriodicalIF":0.0,"publicationDate":"1999-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21221434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and implementation of guidelines for management of sedation and agitation in critically ill patients. 制定和实施危重病人镇静和躁动管理指南。
Pharmacy practice management quarterly Pub Date : 1999-04-01
V Gupta
{"title":"Development and implementation of guidelines for management of sedation and agitation in critically ill patients.","authors":"V Gupta","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The article describes the development, implementation, and success of guidelines for pharmacological management of sedation and agitation in critically ill patients in a community hospital. Guidelines were developed with careful review of published literature and in cooperation with thought leaders in the institution. The primary focus of the guidelines was choice of medication and monitoring parameters and an educational campaign to ensure use of the guidelines. A prospective pharmacist intervention program was initiated for further enforcement of the guidelines. Implementation of these guidelines has resulted in a significant reduction in the cost of sedation and agitation (annual cost savings, > $40,000 per year).</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 1","pages":"19-27"},"PeriodicalIF":0.0,"publicationDate":"1999-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21220010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacists' practice opportunities in women's health. 药剂师在妇女保健方面的实践机会。
Pharmacy practice management quarterly Pub Date : 1999-04-01
D H Berardo
{"title":"Pharmacists' practice opportunities in women's health.","authors":"D H Berardo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The article discusses the rising interest in women's health issues, including demographics, economic issues, and the unique health concerns of the postmenopausal woman. Practice opportunities abound regarding hormone therapy; heart disease; diabetes; osteoporosis; and psychosocial, health and diet, and lifestyle issues for this age group. Barriers to effective communication between the pharmacist and the postmenopausal woman are examined, and suggestions are made to improve communication skills. Patient assessment and the development and implementation of care plans and continued patient monitoring are reviewed. Resources for women's health care are suggested for both the practitioner and the patient.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 1","pages":"42-56"},"PeriodicalIF":0.0,"publicationDate":"1999-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21221433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Joint Commission survey questions and answers. 联合委员会调查问题和答案。
Pharmacy practice management quarterly Pub Date : 1999-04-01
S Arnold, G Aziz, J Betcher, D Williams, K Threlkeld, T Stubblefield
{"title":"Joint Commission survey questions and answers.","authors":"S Arnold,&nbsp;G Aziz,&nbsp;J Betcher,&nbsp;D Williams,&nbsp;K Threlkeld,&nbsp;T Stubblefield","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 1","pages":"63-9"},"PeriodicalIF":0.0,"publicationDate":"1999-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21221435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信